Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3)
Brazil · Delayed Price · Currency is BRL 27.30
+0.43 (1.60%)
Last updated: Mar 13, 2026, 4:18 PM GMT-3
BVMF:OFSA3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,225 | 1,025 | 943.28 | 1,041 | 904.99 | |
Revenue Growth (YoY) | 19.54% | 8.64% | -9.40% | 15.04% | 23.95% |
Cost of Revenue | 591.98 | 507.11 | 511.55 | 513.03 | 457.73 |
Gross Profit | 633.02 | 517.69 | 431.73 | 528.08 | 447.26 |
Selling, General & Admin | 326.77 | 290.58 | 274.08 | 284.47 | 244.23 |
Research & Development | 59.95 | 49.45 | 59.7 | 69.34 | 58.93 |
Other Operating Expenses | 9.82 | -7.87 | -4.74 | 1.15 | -0.28 |
Operating Expenses | 396.54 | 332.16 | 329.04 | 354.96 | 302.88 |
Operating Income | 236.47 | 185.53 | 102.7 | 173.12 | 144.38 |
Interest Expense | -38.21 | -31.49 | -37.07 | -37.45 | -19.63 |
Interest & Investment Income | - | 29.16 | 27.78 | 17.09 | 7.53 |
Currency Exchange Gain (Loss) | 3.58 | -0.47 | 3 | -4.69 | 0.11 |
Other Non Operating Income (Expenses) | 17.42 | -6.93 | -20.47 | -5.21 | -3.43 |
EBT Excluding Unusual Items | 219.27 | 175.8 | 75.94 | 142.86 | 128.96 |
Merger & Restructuring Charges | - | - | - | 1.67 | - |
Impairment of Goodwill | - | - | -18.09 | - | - |
Gain (Loss) on Sale of Assets | - | 1.49 | 0.79 | 3.01 | 2.55 |
Asset Writedown | - | -3.08 | -0.88 | -0.48 | -5.82 |
Legal Settlements | - | 2.9 | - | - | - |
Other Unusual Items | - | - | -3.5 | - | - |
Pretax Income | 219.27 | 177.1 | 54.25 | 147.06 | 125.69 |
Income Tax Expense | -3.05 | 42.77 | 104.23 | 16.41 | 11.73 |
Earnings From Continuing Operations | 222.31 | 134.33 | -49.98 | 130.66 | 113.96 |
Minority Interest in Earnings | - | 0 | 0 | 0.01 | 0.01 |
Net Income | 222.31 | 134.33 | -49.98 | 130.66 | 113.96 |
Net Income to Common | 222.31 | 134.33 | -49.98 | 130.66 | 113.96 |
Net Income Growth | 65.50% | - | - | 14.65% | 27.02% |
Shares Outstanding (Basic) | 54 | 54 | 54 | 54 | 54 |
Shares Outstanding (Diluted) | 54 | 54 | 54 | 54 | 54 |
Shares Change (YoY) | - | - | - | -0.27% | -0.06% |
EPS (Basic) | 4.13 | 2.50 | -0.93 | 2.43 | 2.11 |
EPS (Diluted) | 4.13 | 2.50 | -0.93 | 2.43 | 2.11 |
EPS Growth | 65.50% | - | - | 14.97% | 27.10% |
Free Cash Flow | 70.86 | 56.14 | 165.38 | 37.62 | -9.41 |
Free Cash Flow Per Share | 1.32 | 1.04 | 3.08 | 0.70 | -0.17 |
Dividend Per Share | - | 0.577 | 0.613 | 0.197 | - |
Dividend Growth | - | -5.99% | 211.80% | - | - |
Gross Margin | 51.68% | 50.52% | 45.77% | 50.72% | 49.42% |
Operating Margin | 19.30% | 18.10% | 10.89% | 16.63% | 15.95% |
Profit Margin | 18.15% | 13.11% | -5.30% | 12.55% | 12.59% |
Free Cash Flow Margin | 5.79% | 5.48% | 17.53% | 3.61% | -1.04% |
EBITDA | 274.78 | 207.4 | 126.68 | 195.51 | 164.05 |
EBITDA Margin | 22.43% | 20.24% | 13.43% | 18.78% | 18.13% |
D&A For EBITDA | 38.31 | 21.87 | 23.98 | 22.39 | 19.67 |
EBIT | 236.47 | 185.53 | 102.7 | 173.12 | 144.38 |
EBIT Margin | 19.30% | 18.10% | 10.89% | 16.63% | 15.95% |
Effective Tax Rate | - | 24.15% | 192.12% | 11.15% | 9.34% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.